Oliver Johnson is the Managing Editor at Vertical Magazine. He specializes in writing about medicine and healthcare, healthcare technology, and aviation, with a particular focus on digital health and medical equipment innovations. His work has been featured in notable publications such as The Spectator, Med-Tech Innovation, and Yahoo Sports UK.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Oliver Johnson primarily focuses on press releases and private sector announcements related to 3D printing, manufacturing, consumer electronics, MIT-related research, the helicopter industry, and aerospace. He would be receptive to pitches offering exclusive insights or access to individuals involved in these sectors.
Given his coverage of specific companies' developments and partnerships within the 3D printing space as well as other industries mentioned like aerospace and consumer electronics, he may be interested in receiving pitches from experts who can provide detailed analysis or commentary on emerging technologies and their impact on these sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Oliver Johnson
A unified definition of value – developed with clinicians, patients, and industry – will reduce variation in access to existing products and prevent more medtech suppliers leaving the market, says MTG A new report from the Medical Technology Group is calling on the NHS to adopt a single, nationally consistent definition of value in health
By: Oliver Johnson
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights the significance of the newly-published Life Sciences Jobs Plan. The UK government has published its Life Sciences Jobs Plan, a detailed workforce and skills strategy designed to underpin the wider Life Sciences Sector Plan and support the rapid
By: Oliver Johnson, Sam Davies
Last month MedScan 3D was named the winner of the start-up pitch competition at MedTech Innovation Expo 2026.
By: Oliver Johnson
Stockport NHS Foundation Trust has successfully completed the full deployment of the Clinisys WinPath Laboratory Information Management System (LIMS), marking a significant milestone in its ongoing digital transformation of pathology services. The final phase of the go-live, covering blood transfusion and blood sciences, was completed on 20 April 2026, following an earlier implementation across microbiology
By: Oliver Johnson
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reports on new announcements from the DHSC on how it will boost momentum in the roll-out of value-based procurement (VBP). Officials from the Medical Technology and Innovation Directorate of the Department of Health and Social Care have shared latest
Jason Mitchell is a Partner at MHA, supporting technology and life sciences businesses. A ‘single patient record’ has been discussed for over a decade, but every time benefits of greater data sharing have been raised, so have objections around data privacy and data control. At last, this debate may be coming to a finale as
By: Oliver Johnson
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announced today the official start of the European commercialisation of aXess, marked by the successful treatment of the first commercial patient by Dr Dominik Liebetrau at Artemed Klinikum Munich South, Germany. aXess represents a new category of vascular
By: Oliver Johnson
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, reviews the new NHS England Quality Strategy. NHS England has published a new quality strategy outlining how the NHS in England should deliver consistently higher standards of care over the next decade. Released on 14 July 2026 on behalf
By: Oliver Johnson
Medicaroid Corporation has announced that the CE marking under the Medical Device Regulation (MDR(2017/745)) has been obtained for the hinotori Surgical Robot System. The hinotori was originally approved for manufacturing and marketing in Japan in 2020 and subsequently launched domestically. It thereafter received regulatory approvals in Singapore in 2023 and Malaysia in 2024, and has
By: Oliver Johnson
‘Ride for Rare’ will combine fundraising with real-world validation of VENTO as the UK charity accelerates development towards clinical deployment As many medical technologies are validated in laboratories, Keep Me Breathing is taking a different approach. This July, the UK MedTech charity will embark on a 1,000-mile cycle expedition from the UK to Austria, using the challenge to generate real-world physiological data
